|
Volumn 13, Issue 3, 2003, Pages 178-179
|
The role of aspirin in vernal keratoconjunctivitis
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIHISTAMINIC AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
CYCLOSPORIN;
EMADASTINE DIFUMARATE;
FLUOROMETHOLONE;
NEDOCROMIL;
PLACEBO;
UNCLASSIFIED DRUG;
ADOLESCENT;
ARTICLE;
BLOOD EXAMINATION;
CATARACT;
CHILD;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DRUG CONTRAINDICATION;
DRUG FORMULATION;
DRUG MECHANISM;
FEMALE;
GLAUCOMA;
HISTOPATHOLOGY;
HUMAN;
INFECTION;
INTRAOCULAR PRESSURE;
KERATOCONJUNCTIVITIS;
MAJOR CLINICAL STUDY;
MALE;
RANDOMIZED CONTROLLED TRIAL;
SEASONAL VARIATION;
SLIT LAMP;
TREATMENT OUTCOME;
VERNAL CONJUNCTIVITIS;
ADMINISTRATION, ORAL;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ASPIRIN;
CHILD;
CHILD, PRESCHOOL;
COHORT STUDIES;
CONJUNCTIVITIS, ALLERGIC;
CROMOLYN SODIUM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUOROMETHOLONE;
FOLLOW-UP STUDIES;
HUMANS;
KERATOCONJUNCTIVITIS;
MALE;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
EID: 0038408672
PISSN: 1022386X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (6)
|